Cordlife Group (SG:P8A) has released an update.
Cordlife Group Limited is facing legal challenges after receiving a letter of demand alleging contractual breaches and negligence, alongside a separate claim regarding damage to a client’s cord blood unit stored by the company. The company is contesting the claims and the financial impact is currently uncertain, but if the claims are successful, there could be a negative effect on Cordlife’s financials for the year ending 2024. Shareholders and investors are advised to tread carefully with the company’s shares amidst these legal proceedings.
For further insights into SG:P8A stock, check out TipRanks’ Stock Analysis page.
